We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

USPTO Issues 1st Parthenogenetic Stem Cell Patent

Law360 (June 9, 2010, 11:59 AM EDT) -- The first-ever patent for developing stem cells without creating or destroying a human embryo has been approved and issued to the International Stem Cell Corp., which could provide a way to avoid the ethical controversy associated with stem cell research.

U.S. Patent Number 7,732,202, issued Tuesday by the U.S. Patent and Trademark Office, covers a method of inducing an unfertilized egg to create cells as it would in pregnancy, allowing researchers to derive the same pluripotent cells used in embryonic stem cell research to potentially produce...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.